No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Brentuximab Vedotin
-
Child
-
Hodgkin Disease* / pathology
-
Humans
-
Immunoconjugates* / therapeutic use
-
Lymphoma, Large-Cell, Anaplastic* / diagnosis
-
Lymphoma, Large-Cell, Anaplastic* / drug therapy
-
Neoplasm Recurrence, Local
-
Neoplasm, Residual
Substances
-
Brentuximab Vedotin
-
Immunoconjugates